Nucala - supply shortage
Resolved
mepolizumab
ShortageHuman
Shortage information
The shortage affecting Nucala has been resolved and the information and recommendations which were issued during the shortage no longer apply.
Key facts
- Medicines affected
- Nucala
- Supply shortage status
- Resolved
- International non-proprietary name (INN) or common name
- mepolizumab
- Therapeutic area (MESH)
- Asthma
- Pharmaceutical forms affected
- Pre-filled pen
- Strengths affected
- 40 mg
- 100 mg
- Availability of alternatives
- Yes
Key dates
- First published
- Last updated